IOL Chemicals post Q1 FY26 consolidated profit at Rs. 33.93 Cr
IOLCP has reported total income of Rs. 559.06 crores during the period ended June 30, 2025
IOLCP has reported total income of Rs. 559.06 crores during the period ended June 30, 2025
The partnership aims to co-develop technologies set to revolutionize manufacturing of plasmid DNA (pDNA), a critical raw material for advanced medicines
Revenue from operations rose 14.8 per cent year-on-year to Rs. 3,942 crore
Innovative plate-based internalization reagents designed to deliver accurate, high-throughput, and scalable insights for GPCR and ADC research
Cenexi reports an EBITDA breakeven for the quarter
Athena is also exploring the use of this technology for expanded carrier screening
The average baseline SALT score was 83.8, indicating about 16% scalp hair coverage
Vasograin Plus represents a major advancement in the treatment of migraine
EBITDA rose to Rs. 218.1 crore, a 14.8% year-on-year increase
Subscribe To Our Newsletter & Stay Updated